nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2C18—Ifosfamide—germ cell cancer	0.161	0.197	CbGbCtD
Buprenorphine—CYP2A6—Ifosfamide—germ cell cancer	0.0784	0.0958	CbGbCtD
Buprenorphine—ABCG2—Dactinomycin—germ cell cancer	0.0615	0.0751	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0536	0.0655	CbGbCtD
Buprenorphine—CYP3A7—Ifosfamide—germ cell cancer	0.0536	0.0655	CbGbCtD
Buprenorphine—CYP3A5—Ifosfamide—germ cell cancer	0.0402	0.0491	CbGbCtD
Buprenorphine—CYP2C8—Ifosfamide—germ cell cancer	0.0387	0.0472	CbGbCtD
Buprenorphine—ABCG2—Cisplatin—germ cell cancer	0.0353	0.0431	CbGbCtD
Buprenorphine—ABCG2—Etoposide—germ cell cancer	0.0347	0.0424	CbGbCtD
Buprenorphine—CYP2C19—Ifosfamide—germ cell cancer	0.0324	0.0396	CbGbCtD
Buprenorphine—CYP2C9—Ifosfamide—germ cell cancer	0.027	0.0329	CbGbCtD
Buprenorphine—ABCG2—Methotrexate—germ cell cancer	0.0229	0.028	CbGbCtD
Buprenorphine—ABCB1—Dactinomycin—germ cell cancer	0.0222	0.0271	CbGbCtD
Buprenorphine—CYP3A5—Etoposide—germ cell cancer	0.0192	0.0235	CbGbCtD
Buprenorphine—CYP2C8—Etoposide—germ cell cancer	0.0185	0.0226	CbGbCtD
Buprenorphine—CYP3A4—Ifosfamide—germ cell cancer	0.0157	0.0192	CbGbCtD
Buprenorphine—CYP1A2—Etoposide—germ cell cancer	0.0143	0.0175	CbGbCtD
Buprenorphine—ABCB1—Vinblastine—germ cell cancer	0.0139	0.017	CbGbCtD
Buprenorphine—CYP2C9—Cisplatin—germ cell cancer	0.0131	0.016	CbGbCtD
Buprenorphine—CYP2D6—Vinblastine—germ cell cancer	0.0131	0.016	CbGbCtD
Buprenorphine—ABCB1—Cisplatin—germ cell cancer	0.0127	0.0156	CbGbCtD
Buprenorphine—ABCB1—Etoposide—germ cell cancer	0.0125	0.0153	CbGbCtD
Buprenorphine—CYP3A4—Vinblastine—germ cell cancer	0.00832	0.0102	CbGbCtD
Buprenorphine—ABCB1—Methotrexate—germ cell cancer	0.00827	0.0101	CbGbCtD
Buprenorphine—CYP3A4—Etoposide—germ cell cancer	0.0075	0.00915	CbGbCtD
Buprenorphine—CYP2C9—cardial valve—germ cell cancer	0.0064	0.117	CbGeAlD
Buprenorphine—OPRM1—telencephalic ventricle—germ cell cancer	0.00283	0.0516	CbGeAlD
Buprenorphine—OPRD1—ganglion—germ cell cancer	0.00258	0.0471	CbGeAlD
Buprenorphine—OPRL1—brainstem—germ cell cancer	0.00218	0.0397	CbGeAlD
Buprenorphine—OPRL1—telencephalon—germ cell cancer	0.00193	0.0353	CbGeAlD
Buprenorphine—CYP2C19—urine—germ cell cancer	0.00178	0.0325	CbGeAlD
Buprenorphine—OPRM1—ganglion—germ cell cancer	0.00176	0.0321	CbGeAlD
Buprenorphine—CYP1A2—urine—germ cell cancer	0.00146	0.0265	CbGeAlD
Buprenorphine—OPRL1—adrenal gland—germ cell cancer	0.00141	0.0256	CbGeAlD
Buprenorphine—CYP2C9—urine—germ cell cancer	0.00138	0.0252	CbGeAlD
Buprenorphine—OPRL1—spinal cord—germ cell cancer	0.00136	0.0247	CbGeAlD
Buprenorphine—OPRL1—endocrine gland—germ cell cancer	0.00122	0.0222	CbGeAlD
Buprenorphine—OPRL1—head—germ cell cancer	0.0012	0.022	CbGeAlD
Buprenorphine—OPRL1—testis—germ cell cancer	0.00116	0.0212	CbGeAlD
Buprenorphine—CYP3A4—urine—germ cell cancer	0.00105	0.0192	CbGeAlD
Buprenorphine—CYP2D6—urine—germ cell cancer	0.00104	0.0189	CbGeAlD
Buprenorphine—OPRD1—telencephalon—germ cell cancer	0.000997	0.0182	CbGeAlD
Buprenorphine—OPRL1—brain—germ cell cancer	0.000873	0.0159	CbGeAlD
Buprenorphine—OPRL1—lymph node—germ cell cancer	0.000844	0.0154	CbGeAlD
Buprenorphine—UGT1A9—endocrine gland—germ cell cancer	0.000795	0.0145	CbGeAlD
Buprenorphine—OPRM1—brainstem—germ cell cancer	0.000766	0.014	CbGeAlD
Buprenorphine—CYP2C18—endocrine gland—germ cell cancer	0.000695	0.0127	CbGeAlD
Buprenorphine—OPRM1—telencephalon—germ cell cancer	0.00068	0.0124	CbGeAlD
Buprenorphine—CYP3A7—endocrine gland—germ cell cancer	0.000661	0.0121	CbGeAlD
Buprenorphine—OPRD1—head—germ cell cancer	0.000621	0.0113	CbGeAlD
Buprenorphine—OPRK1—head—germ cell cancer	0.000595	0.0108	CbGeAlD
Buprenorphine—OPRK1—cerebellum—germ cell cancer	0.000531	0.00967	CbGeAlD
Buprenorphine—ABCG2—trigeminal ganglion—germ cell cancer	0.000506	0.00922	CbGeAlD
Buprenorphine—OPRM1—midbrain—germ cell cancer	0.000488	0.0089	CbGeAlD
Buprenorphine—OPRM1—spinal cord—germ cell cancer	0.000476	0.00868	CbGeAlD
Buprenorphine—OPRD1—brain—germ cell cancer	0.00045	0.0082	CbGeAlD
Buprenorphine—OPRK1—brain—germ cell cancer	0.000431	0.00786	CbGeAlD
Buprenorphine—OPRM1—endocrine gland—germ cell cancer	0.000429	0.00781	CbGeAlD
Buprenorphine—OPRM1—head—germ cell cancer	0.000423	0.00771	CbGeAlD
Buprenorphine—OPRM1—testis—germ cell cancer	0.000409	0.00745	CbGeAlD
Buprenorphine—CYP2A6—cerebellum—germ cell cancer	0.000405	0.00737	CbGeAlD
Buprenorphine—ABCB1—blood vessel—germ cell cancer	0.000404	0.00736	CbGeAlD
Buprenorphine—ABCG2—telencephalon—germ cell cancer	0.000398	0.00724	CbGeAlD
Buprenorphine—ABCG2—decidua—germ cell cancer	0.000377	0.00687	CbGeAlD
Buprenorphine—CYP2C8—pituitary gland—germ cell cancer	0.000333	0.00607	CbGeAlD
Buprenorphine—ABCG2—uterus—germ cell cancer	0.00033	0.00601	CbGeAlD
Buprenorphine—CYP2A6—brain—germ cell cancer	0.000329	0.00599	CbGeAlD
Buprenorphine—ABCG2—pituitary gland—germ cell cancer	0.000324	0.0059	CbGeAlD
Buprenorphine—ABCG2—medulla oblongata—germ cell cancer	0.000312	0.00569	CbGeAlD
Buprenorphine—Malaise—Ifosfamide—germ cell cancer	0.000312	0.00247	CcSEcCtD
Buprenorphine—Vertigo—Ifosfamide—germ cell cancer	0.000311	0.00246	CcSEcCtD
Buprenorphine—Urinary tract disorder—Etoposide—germ cell cancer	0.00031	0.00245	CcSEcCtD
Buprenorphine—Immune system disorder—Cisplatin—germ cell cancer	0.000309	0.00245	CcSEcCtD
Buprenorphine—Abdominal pain—Vinblastine—germ cell cancer	0.000309	0.00245	CcSEcCtD
Buprenorphine—Mediastinal disorder—Cisplatin—germ cell cancer	0.000309	0.00244	CcSEcCtD
Buprenorphine—Hypotension—Bleomycin—germ cell cancer	0.000308	0.00244	CcSEcCtD
Buprenorphine—Oedema—Dactinomycin—germ cell cancer	0.000308	0.00244	CcSEcCtD
Buprenorphine—Urethral disorder—Etoposide—germ cell cancer	0.000307	0.00244	CcSEcCtD
Buprenorphine—CYP2D6—brainstem—germ cell cancer	0.000307	0.0056	CbGeAlD
Buprenorphine—OPRM1—brain—germ cell cancer	0.000307	0.00559	CbGeAlD
Buprenorphine—Infection—Dactinomycin—germ cell cancer	0.000306	0.00242	CcSEcCtD
Buprenorphine—Palpitations—Ifosfamide—germ cell cancer	0.000306	0.00242	CcSEcCtD
Buprenorphine—Cough—Ifosfamide—germ cell cancer	0.000302	0.00239	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000301	0.00238	CcSEcCtD
Buprenorphine—Convulsion—Ifosfamide—germ cell cancer	0.0003	0.00237	CcSEcCtD
Buprenorphine—Hypertension—Ifosfamide—germ cell cancer	0.000298	0.00236	CcSEcCtD
Buprenorphine—Erythema—Cisplatin—germ cell cancer	0.000298	0.00236	CcSEcCtD
Buprenorphine—Malnutrition—Cisplatin—germ cell cancer	0.000298	0.00236	CcSEcCtD
Buprenorphine—Paraesthesia—Bleomycin—germ cell cancer	0.000296	0.00235	CcSEcCtD
Buprenorphine—CYP2C19—endocrine gland—germ cell cancer	0.000295	0.00538	CbGeAlD
Buprenorphine—Dyspnoea—Bleomycin—germ cell cancer	0.000294	0.00233	CcSEcCtD
Buprenorphine—Chest pain—Ifosfamide—germ cell cancer	0.000294	0.00233	CcSEcCtD
Buprenorphine—Arthralgia—Ifosfamide—germ cell cancer	0.000294	0.00233	CcSEcCtD
Buprenorphine—Myalgia—Ifosfamide—germ cell cancer	0.000294	0.00233	CcSEcCtD
Buprenorphine—Flatulence—Cisplatin—germ cell cancer	0.000294	0.00233	CcSEcCtD
Buprenorphine—Anorexia—Dactinomycin—germ cell cancer	0.000294	0.00233	CcSEcCtD
Buprenorphine—Eye disorder—Etoposide—germ cell cancer	0.000293	0.00232	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000292	0.00232	CcSEcCtD
Buprenorphine—Flushing—Etoposide—germ cell cancer	0.000291	0.00231	CcSEcCtD
Buprenorphine—Cardiac disorder—Etoposide—germ cell cancer	0.000291	0.00231	CcSEcCtD
Buprenorphine—Discomfort—Ifosfamide—germ cell cancer	0.000291	0.0023	CcSEcCtD
Buprenorphine—ABCG2—adrenal gland—germ cell cancer	0.000289	0.00527	CbGeAlD
Buprenorphine—Hypersensitivity—Vinblastine—germ cell cancer	0.000288	0.00228	CcSEcCtD
Buprenorphine—Decreased appetite—Bleomycin—germ cell cancer	0.000287	0.00227	CcSEcCtD
Buprenorphine—Visual disturbance—Methotrexate—germ cell cancer	0.000287	0.00227	CcSEcCtD
Buprenorphine—Muscle spasms—Cisplatin—germ cell cancer	0.000287	0.00227	CcSEcCtD
Buprenorphine—ABCG2—midbrain—germ cell cancer	0.000285	0.0052	CbGeAlD
Buprenorphine—Angiopathy—Etoposide—germ cell cancer	0.000285	0.00225	CcSEcCtD
Buprenorphine—Confusional state—Ifosfamide—germ cell cancer	0.000285	0.00225	CcSEcCtD
Buprenorphine—Immune system disorder—Etoposide—germ cell cancer	0.000283	0.00224	CcSEcCtD
Buprenorphine—Mediastinal disorder—Etoposide—germ cell cancer	0.000283	0.00224	CcSEcCtD
Buprenorphine—Pain—Bleomycin—germ cell cancer	0.000282	0.00224	CcSEcCtD
Buprenorphine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000282	0.00224	CcSEcCtD
Buprenorphine—Oedema—Ifosfamide—germ cell cancer	0.000282	0.00224	CcSEcCtD
Buprenorphine—Chills—Etoposide—germ cell cancer	0.000281	0.00223	CcSEcCtD
Buprenorphine—Vision blurred—Cisplatin—germ cell cancer	0.000281	0.00223	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000281	0.00222	CcSEcCtD
Buprenorphine—Asthenia—Vinblastine—germ cell cancer	0.00028	0.00222	CcSEcCtD
Buprenorphine—Infection—Ifosfamide—germ cell cancer	0.00028	0.00222	CcSEcCtD
Buprenorphine—ABCG2—bone marrow—germ cell cancer	0.00028	0.0051	CbGeAlD
Buprenorphine—Tremor—Cisplatin—germ cell cancer	0.000279	0.00221	CcSEcCtD
Buprenorphine—ABCG2—spinal cord—germ cell cancer	0.000279	0.00508	CbGeAlD
Buprenorphine—Lethargy—Methotrexate—germ cell cancer	0.000277	0.0022	CcSEcCtD
Buprenorphine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000277	0.00219	CcSEcCtD
Buprenorphine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000277	0.00219	CcSEcCtD
Buprenorphine—Skin disorder—Ifosfamide—germ cell cancer	0.000274	0.00217	CcSEcCtD
Buprenorphine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000273	0.00216	CcSEcCtD
Buprenorphine—CYP2D6—telencephalon—germ cell cancer	0.000273	0.00497	CbGeAlD
Buprenorphine—Feeling abnormal—Bleomycin—germ cell cancer	0.000272	0.00216	CcSEcCtD
Buprenorphine—Osteoarthritis—Methotrexate—germ cell cancer	0.000272	0.00215	CcSEcCtD
Buprenorphine—ABCG2—female gonad—germ cell cancer	0.00027	0.00491	CbGeAlD
Buprenorphine—Anorexia—Ifosfamide—germ cell cancer	0.000269	0.00213	CcSEcCtD
Buprenorphine—Malaise—Cisplatin—germ cell cancer	0.000269	0.00213	CcSEcCtD
Buprenorphine—Decreased appetite—Dactinomycin—germ cell cancer	0.000268	0.00212	CcSEcCtD
Buprenorphine—Diarrhoea—Vinblastine—germ cell cancer	0.000267	0.00212	CcSEcCtD
Buprenorphine—Dysgeusia—Etoposide—germ cell cancer	0.000267	0.00212	CcSEcCtD
Buprenorphine—Fatigue—Dactinomycin—germ cell cancer	0.000265	0.0021	CcSEcCtD
Buprenorphine—Back pain—Etoposide—germ cell cancer	0.000264	0.00209	CcSEcCtD
Buprenorphine—Hypotension—Ifosfamide—germ cell cancer	0.000264	0.00209	CcSEcCtD
Buprenorphine—Pain—Dactinomycin—germ cell cancer	0.000263	0.00209	CcSEcCtD
Buprenorphine—Muscle spasms—Etoposide—germ cell cancer	0.000263	0.00208	CcSEcCtD
Buprenorphine—Urticaria—Bleomycin—germ cell cancer	0.000262	0.00208	CcSEcCtD
Buprenorphine—Body temperature increased—Bleomycin—germ cell cancer	0.000261	0.00207	CcSEcCtD
Buprenorphine—Dizziness—Vinblastine—germ cell cancer	0.000258	0.00205	CcSEcCtD
Buprenorphine—Convulsion—Cisplatin—germ cell cancer	0.000258	0.00205	CcSEcCtD
Buprenorphine—CYP2C8—endocrine gland—germ cell cancer	0.000258	0.0047	CbGeAlD
Buprenorphine—Mood swings—Methotrexate—germ cell cancer	0.000257	0.00204	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000257	0.00204	CcSEcCtD
Buprenorphine—Myalgia—Cisplatin—germ cell cancer	0.000254	0.00201	CcSEcCtD
Buprenorphine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000254	0.00201	CcSEcCtD
Buprenorphine—Paraesthesia—Ifosfamide—germ cell cancer	0.000253	0.00201	CcSEcCtD
Buprenorphine—Ill-defined disorder—Etoposide—germ cell cancer	0.000253	0.00201	CcSEcCtD
Buprenorphine—Anxiety—Cisplatin—germ cell cancer	0.000253	0.002	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000252	0.002	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000252	0.00199	CcSEcCtD
Buprenorphine—Dyspnoea—Ifosfamide—germ cell cancer	0.000252	0.00199	CcSEcCtD
Buprenorphine—Somnolence—Ifosfamide—germ cell cancer	0.000251	0.00199	CcSEcCtD
Buprenorphine—Discomfort—Cisplatin—germ cell cancer	0.000251	0.00199	CcSEcCtD
Buprenorphine—CYP3A5—female gonad—germ cell cancer	0.00025	0.00456	CbGeAlD
Buprenorphine—ABCB1—trigeminal ganglion—germ cell cancer	0.00025	0.00455	CbGeAlD
Buprenorphine—Vomiting—Vinblastine—germ cell cancer	0.000249	0.00197	CcSEcCtD
Buprenorphine—Malaise—Etoposide—germ cell cancer	0.000246	0.00195	CcSEcCtD
Buprenorphine—CYP2C8—testis—germ cell cancer	0.000246	0.00448	CbGeAlD
Buprenorphine—Breast disorder—Methotrexate—germ cell cancer	0.000245	0.00194	CcSEcCtD
Buprenorphine—Vertigo—Etoposide—germ cell cancer	0.000245	0.00194	CcSEcCtD
Buprenorphine—Decreased appetite—Ifosfamide—germ cell cancer	0.000245	0.00194	CcSEcCtD
Buprenorphine—Headache—Vinblastine—germ cell cancer	0.000245	0.00194	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000244	0.00193	CcSEcCtD
Buprenorphine—Abdominal pain—Dactinomycin—germ cell cancer	0.000243	0.00193	CcSEcCtD
Buprenorphine—Body temperature increased—Dactinomycin—germ cell cancer	0.000243	0.00193	CcSEcCtD
Buprenorphine—Fatigue—Ifosfamide—germ cell cancer	0.000243	0.00193	CcSEcCtD
Buprenorphine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000243	0.00193	CcSEcCtD
Buprenorphine—Oedema—Cisplatin—germ cell cancer	0.000243	0.00193	CcSEcCtD
Buprenorphine—Hypersensitivity—Bleomycin—germ cell cancer	0.000243	0.00193	CcSEcCtD
Buprenorphine—Infection—Cisplatin—germ cell cancer	0.000242	0.00191	CcSEcCtD
Buprenorphine—CYP1A2—endocrine gland—germ cell cancer	0.000241	0.0044	CbGeAlD
Buprenorphine—Pain—Ifosfamide—germ cell cancer	0.000241	0.00191	CcSEcCtD
Buprenorphine—Constipation—Ifosfamide—germ cell cancer	0.000241	0.00191	CcSEcCtD
Buprenorphine—ABCB1—embryo—germ cell cancer	0.000241	0.00439	CbGeAlD
Buprenorphine—Loss of consciousness—Etoposide—germ cell cancer	0.00024	0.0019	CcSEcCtD
Buprenorphine—ABCG2—testis—germ cell cancer	0.000239	0.00436	CbGeAlD
Buprenorphine—Nervous system disorder—Cisplatin—germ cell cancer	0.000239	0.00189	CcSEcCtD
Buprenorphine—Cough—Etoposide—germ cell cancer	0.000238	0.00189	CcSEcCtD
Buprenorphine—Tachycardia—Cisplatin—germ cell cancer	0.000237	0.00188	CcSEcCtD
Buprenorphine—Asthenia—Bleomycin—germ cell cancer	0.000237	0.00188	CcSEcCtD
Buprenorphine—Convulsion—Etoposide—germ cell cancer	0.000237	0.00187	CcSEcCtD
Buprenorphine—Skin disorder—Cisplatin—germ cell cancer	0.000236	0.00187	CcSEcCtD
Buprenorphine—Hypertension—Etoposide—germ cell cancer	0.000236	0.00187	CcSEcCtD
Buprenorphine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000235	0.00186	CcSEcCtD
Buprenorphine—Asthma—Methotrexate—germ cell cancer	0.000235	0.00186	CcSEcCtD
Buprenorphine—Pruritus—Bleomycin—germ cell cancer	0.000234	0.00185	CcSEcCtD
Buprenorphine—CYP3A5—endocrine gland—germ cell cancer	0.000233	0.00424	CbGeAlD
Buprenorphine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000233	0.00184	CcSEcCtD
Buprenorphine—Chest pain—Etoposide—germ cell cancer	0.000232	0.00184	CcSEcCtD
Buprenorphine—Nausea—Vinblastine—germ cell cancer	0.000232	0.00184	CcSEcCtD
Buprenorphine—Anorexia—Cisplatin—germ cell cancer	0.000232	0.00184	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000231	0.00183	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000231	0.00183	CcSEcCtD
Buprenorphine—Discomfort—Etoposide—germ cell cancer	0.00023	0.00182	CcSEcCtD
Buprenorphine—CYP2C9—endocrine gland—germ cell cancer	0.000229	0.00417	CbGeAlD
Buprenorphine—Hypotension—Cisplatin—germ cell cancer	0.000227	0.0018	CcSEcCtD
Buprenorphine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000227	0.0018	CcSEcCtD
Buprenorphine—Abdominal discomfort—Methotrexate—germ cell cancer	0.000225	0.00178	CcSEcCtD
Buprenorphine—Confusional state—Etoposide—germ cell cancer	0.000225	0.00178	CcSEcCtD
Buprenorphine—Urticaria—Ifosfamide—germ cell cancer	0.000224	0.00178	CcSEcCtD
Buprenorphine—Abdominal pain—Ifosfamide—germ cell cancer	0.000223	0.00177	CcSEcCtD
Buprenorphine—Body temperature increased—Ifosfamide—germ cell cancer	0.000223	0.00177	CcSEcCtD
Buprenorphine—Anaphylactic shock—Etoposide—germ cell cancer	0.000223	0.00177	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000222	0.00176	CcSEcCtD
Buprenorphine—Infection—Etoposide—germ cell cancer	0.000221	0.00175	CcSEcCtD
Buprenorphine—Asthenia—Dactinomycin—germ cell cancer	0.000221	0.00175	CcSEcCtD
Buprenorphine—ABCG2—cerebellum—germ cell cancer	0.000221	0.00402	CbGeAlD
Buprenorphine—Paraesthesia—Cisplatin—germ cell cancer	0.000218	0.00173	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000218	0.00173	CcSEcCtD
Buprenorphine—Tachycardia—Etoposide—germ cell cancer	0.000217	0.00172	CcSEcCtD
Buprenorphine—Dyspnoea—Cisplatin—germ cell cancer	0.000217	0.00172	CcSEcCtD
Buprenorphine—Skin disorder—Etoposide—germ cell cancer	0.000216	0.00171	CcSEcCtD
Buprenorphine—Hyperhidrosis—Etoposide—germ cell cancer	0.000215	0.00171	CcSEcCtD
Buprenorphine—ABCB1—retina—germ cell cancer	0.000213	0.00388	CbGeAlD
Buprenorphine—Anorexia—Etoposide—germ cell cancer	0.000212	0.00168	CcSEcCtD
Buprenorphine—Decreased appetite—Cisplatin—germ cell cancer	0.000211	0.00168	CcSEcCtD
Buprenorphine—Diarrhoea—Dactinomycin—germ cell cancer	0.000211	0.00167	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00021	0.00166	CcSEcCtD
Buprenorphine—Vomiting—Bleomycin—germ cell cancer	0.00021	0.00166	CcSEcCtD
Buprenorphine—Infestation NOS—Methotrexate—germ cell cancer	0.000209	0.00166	CcSEcCtD
Buprenorphine—Infestation—Methotrexate—germ cell cancer	0.000209	0.00166	CcSEcCtD
Buprenorphine—Depression—Methotrexate—germ cell cancer	0.000209	0.00165	CcSEcCtD
Buprenorphine—Hypotension—Etoposide—germ cell cancer	0.000208	0.00165	CcSEcCtD
Buprenorphine—Rash—Bleomycin—germ cell cancer	0.000208	0.00165	CcSEcCtD
Buprenorphine—Pain—Cisplatin—germ cell cancer	0.000208	0.00165	CcSEcCtD
Buprenorphine—Dermatitis—Bleomycin—germ cell cancer	0.000208	0.00165	CcSEcCtD
Buprenorphine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000208	0.00165	CcSEcCtD
Buprenorphine—Conjunctivitis—Methotrexate—germ cell cancer	0.000203	0.00161	CcSEcCtD
Buprenorphine—Asthenia—Ifosfamide—germ cell cancer	0.000202	0.0016	CcSEcCtD
Buprenorphine—Sweating—Methotrexate—germ cell cancer	0.000201	0.00159	CcSEcCtD
Buprenorphine—Feeling abnormal—Cisplatin—germ cell cancer	0.0002	0.00159	CcSEcCtD
Buprenorphine—Paraesthesia—Etoposide—germ cell cancer	0.0002	0.00159	CcSEcCtD
Buprenorphine—Pruritus—Ifosfamide—germ cell cancer	0.0002	0.00158	CcSEcCtD
Buprenorphine—Dyspnoea—Etoposide—germ cell cancer	0.000199	0.00157	CcSEcCtD
Buprenorphine—Somnolence—Etoposide—germ cell cancer	0.000198	0.00157	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000198	0.00157	CcSEcCtD
Buprenorphine—Nausea—Bleomycin—germ cell cancer	0.000196	0.00155	CcSEcCtD
Buprenorphine—ABCB1—telencephalon—germ cell cancer	0.000196	0.00357	CbGeAlD
Buprenorphine—Vomiting—Dactinomycin—germ cell cancer	0.000196	0.00155	CcSEcCtD
Buprenorphine—Rash—Dactinomycin—germ cell cancer	0.000194	0.00154	CcSEcCtD
Buprenorphine—Decreased appetite—Etoposide—germ cell cancer	0.000194	0.00153	CcSEcCtD
Buprenorphine—Diarrhoea—Ifosfamide—germ cell cancer	0.000193	0.00153	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000192	0.00152	CcSEcCtD
Buprenorphine—Body temperature increased—Cisplatin—germ cell cancer	0.000192	0.00152	CcSEcCtD
Buprenorphine—Fatigue—Etoposide—germ cell cancer	0.000192	0.00152	CcSEcCtD
Buprenorphine—Constipation—Etoposide—germ cell cancer	0.000191	0.00151	CcSEcCtD
Buprenorphine—Pain—Etoposide—germ cell cancer	0.000191	0.00151	CcSEcCtD
Buprenorphine—Dizziness—Ifosfamide—germ cell cancer	0.000187	0.00148	CcSEcCtD
Buprenorphine—Pharyngitis—Methotrexate—germ cell cancer	0.000186	0.00148	CcSEcCtD
Buprenorphine—ABCB1—decidua—germ cell cancer	0.000186	0.00339	CbGeAlD
Buprenorphine—Urinary tract disorder—Methotrexate—germ cell cancer	0.000186	0.00147	CcSEcCtD
Buprenorphine—CYP2D6—female gonad—germ cell cancer	0.000185	0.00337	CbGeAlD
Buprenorphine—CYP2C8—brain—germ cell cancer	0.000184	0.00336	CbGeAlD
Buprenorphine—Urethral disorder—Methotrexate—germ cell cancer	0.000184	0.00146	CcSEcCtD
Buprenorphine—Feeling abnormal—Etoposide—germ cell cancer	0.000184	0.00145	CcSEcCtD
Buprenorphine—Nausea—Dactinomycin—germ cell cancer	0.000183	0.00145	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000182	0.00144	CcSEcCtD
Buprenorphine—Visual impairment—Methotrexate—germ cell cancer	0.000181	0.00143	CcSEcCtD
Buprenorphine—Vomiting—Ifosfamide—germ cell cancer	0.000179	0.00142	CcSEcCtD
Buprenorphine—ABCG2—brain—germ cell cancer	0.000179	0.00327	CbGeAlD
Buprenorphine—Hypersensitivity—Cisplatin—germ cell cancer	0.000179	0.00142	CcSEcCtD
Buprenorphine—Rash—Ifosfamide—germ cell cancer	0.000178	0.00141	CcSEcCtD
Buprenorphine—Dermatitis—Ifosfamide—germ cell cancer	0.000178	0.00141	CcSEcCtD
Buprenorphine—Urticaria—Etoposide—germ cell cancer	0.000177	0.0014	CcSEcCtD
Buprenorphine—Abdominal pain—Etoposide—germ cell cancer	0.000176	0.0014	CcSEcCtD
Buprenorphine—Body temperature increased—Etoposide—germ cell cancer	0.000176	0.0014	CcSEcCtD
Buprenorphine—Eye disorder—Methotrexate—germ cell cancer	0.000176	0.00139	CcSEcCtD
Buprenorphine—Tinnitus—Methotrexate—germ cell cancer	0.000175	0.00139	CcSEcCtD
Buprenorphine—CYP3A4—endocrine gland—germ cell cancer	0.000175	0.00318	CbGeAlD
Buprenorphine—Asthenia—Cisplatin—germ cell cancer	0.000175	0.00138	CcSEcCtD
Buprenorphine—Cardiac disorder—Methotrexate—germ cell cancer	0.000174	0.00138	CcSEcCtD
Buprenorphine—ABCG2—lymph node—germ cell cancer	0.000173	0.00316	CbGeAlD
Buprenorphine—CYP2D6—endocrine gland—germ cell cancer	0.000172	0.00313	CbGeAlD
Buprenorphine—Angiopathy—Methotrexate—germ cell cancer	0.00017	0.00135	CcSEcCtD
Buprenorphine—Immune system disorder—Methotrexate—germ cell cancer	0.00017	0.00134	CcSEcCtD
Buprenorphine—CYP2D6—head—germ cell cancer	0.00017	0.00309	CbGeAlD
Buprenorphine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000169	0.00134	CcSEcCtD
Buprenorphine—Chills—Methotrexate—germ cell cancer	0.000169	0.00134	CcSEcCtD
Buprenorphine—Nausea—Ifosfamide—germ cell cancer	0.000168	0.00133	CcSEcCtD
Buprenorphine—Diarrhoea—Cisplatin—germ cell cancer	0.000166	0.00132	CcSEcCtD
Buprenorphine—Mental disorder—Methotrexate—germ cell cancer	0.000165	0.0013	CcSEcCtD
Buprenorphine—Hypersensitivity—Etoposide—germ cell cancer	0.000164	0.0013	CcSEcCtD
Buprenorphine—CYP2D6—testis—germ cell cancer	0.000164	0.00299	CbGeAlD
Buprenorphine—ABCB1—gonad—germ cell cancer	0.000164	0.00298	CbGeAlD
Buprenorphine—Malnutrition—Methotrexate—germ cell cancer	0.000164	0.0013	CcSEcCtD
Buprenorphine—Erythema—Methotrexate—germ cell cancer	0.000164	0.0013	CcSEcCtD
Buprenorphine—ABCB1—uterus—germ cell cancer	0.000163	0.00296	CbGeAlD
Buprenorphine—Dysgeusia—Methotrexate—germ cell cancer	0.00016	0.00127	CcSEcCtD
Buprenorphine—Asthenia—Etoposide—germ cell cancer	0.00016	0.00127	CcSEcCtD
Buprenorphine—ABCB1—pituitary gland—germ cell cancer	0.00016	0.00291	CbGeAlD
Buprenorphine—Back pain—Methotrexate—germ cell cancer	0.000158	0.00125	CcSEcCtD
Buprenorphine—Pruritus—Etoposide—germ cell cancer	0.000158	0.00125	CcSEcCtD
Buprenorphine—Vomiting—Cisplatin—germ cell cancer	0.000155	0.00123	CcSEcCtD
Buprenorphine—Vision blurred—Methotrexate—germ cell cancer	0.000154	0.00122	CcSEcCtD
Buprenorphine—ABCB1—medulla oblongata—germ cell cancer	0.000154	0.00281	CbGeAlD
Buprenorphine—Rash—Cisplatin—germ cell cancer	0.000153	0.00121	CcSEcCtD
Buprenorphine—Dermatitis—Cisplatin—germ cell cancer	0.000153	0.00121	CcSEcCtD
Buprenorphine—Diarrhoea—Etoposide—germ cell cancer	0.000152	0.00121	CcSEcCtD
Buprenorphine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000152	0.0012	CcSEcCtD
Buprenorphine—CYP2D6—cerebellum—germ cell cancer	0.000151	0.00276	CbGeAlD
Buprenorphine—Malaise—Methotrexate—germ cell cancer	0.000147	0.00117	CcSEcCtD
Buprenorphine—Dizziness—Etoposide—germ cell cancer	0.000147	0.00117	CcSEcCtD
Buprenorphine—Vertigo—Methotrexate—germ cell cancer	0.000147	0.00116	CcSEcCtD
Buprenorphine—Nausea—Cisplatin—germ cell cancer	0.000144	0.00114	CcSEcCtD
Buprenorphine—Cough—Methotrexate—germ cell cancer	0.000143	0.00113	CcSEcCtD
Buprenorphine—ABCB1—adrenal gland—germ cell cancer	0.000143	0.0026	CbGeAlD
Buprenorphine—Convulsion—Methotrexate—germ cell cancer	0.000142	0.00112	CcSEcCtD
Buprenorphine—Vomiting—Etoposide—germ cell cancer	0.000142	0.00112	CcSEcCtD
Buprenorphine—ABCB1—midbrain—germ cell cancer	0.000141	0.00257	CbGeAlD
Buprenorphine—Rash—Etoposide—germ cell cancer	0.000141	0.00111	CcSEcCtD
Buprenorphine—Dermatitis—Etoposide—germ cell cancer	0.00014	0.00111	CcSEcCtD
Buprenorphine—Headache—Etoposide—germ cell cancer	0.00014	0.00111	CcSEcCtD
Buprenorphine—Arthralgia—Methotrexate—germ cell cancer	0.000139	0.0011	CcSEcCtD
Buprenorphine—Chest pain—Methotrexate—germ cell cancer	0.000139	0.0011	CcSEcCtD
Buprenorphine—Myalgia—Methotrexate—germ cell cancer	0.000139	0.0011	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000138	0.0011	CcSEcCtD
Buprenorphine—ABCB1—bone marrow—germ cell cancer	0.000138	0.00251	CbGeAlD
Buprenorphine—Discomfort—Methotrexate—germ cell cancer	0.000138	0.00109	CcSEcCtD
Buprenorphine—ABCB1—spinal cord—germ cell cancer	0.000137	0.0025	CbGeAlD
Buprenorphine—Confusional state—Methotrexate—germ cell cancer	0.000135	0.00107	CcSEcCtD
Buprenorphine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000133	0.00106	CcSEcCtD
Buprenorphine—ABCB1—female gonad—germ cell cancer	0.000133	0.00242	CbGeAlD
Buprenorphine—Infection—Methotrexate—germ cell cancer	0.000133	0.00105	CcSEcCtD
Buprenorphine—Nausea—Etoposide—germ cell cancer	0.000132	0.00105	CcSEcCtD
Buprenorphine—Nervous system disorder—Methotrexate—germ cell cancer	0.000131	0.00104	CcSEcCtD
Buprenorphine—Skin disorder—Methotrexate—germ cell cancer	0.00013	0.00103	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000129	0.00102	CcSEcCtD
Buprenorphine—Anorexia—Methotrexate—germ cell cancer	0.000127	0.00101	CcSEcCtD
Buprenorphine—Hypotension—Methotrexate—germ cell cancer	0.000125	0.000988	CcSEcCtD
Buprenorphine—ABCB1—endocrine gland—germ cell cancer	0.000124	0.00225	CbGeAlD
Buprenorphine—CYP2D6—brain—germ cell cancer	0.000123	0.00224	CbGeAlD
Buprenorphine—ABCB1—head—germ cell cancer	0.000122	0.00222	CbGeAlD
Buprenorphine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000122	0.000963	CcSEcCtD
Buprenorphine—Insomnia—Methotrexate—germ cell cancer	0.000121	0.000956	CcSEcCtD
Buprenorphine—Paraesthesia—Methotrexate—germ cell cancer	0.00012	0.000949	CcSEcCtD
Buprenorphine—Dyspnoea—Methotrexate—germ cell cancer	0.000119	0.000943	CcSEcCtD
Buprenorphine—Somnolence—Methotrexate—germ cell cancer	0.000119	0.00094	CcSEcCtD
Buprenorphine—ABCB1—testis—germ cell cancer	0.000118	0.00215	CbGeAlD
Buprenorphine—Dyspepsia—Methotrexate—germ cell cancer	0.000117	0.000931	CcSEcCtD
Buprenorphine—Decreased appetite—Methotrexate—germ cell cancer	0.000116	0.000919	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000115	0.000913	CcSEcCtD
Buprenorphine—Fatigue—Methotrexate—germ cell cancer	0.000115	0.000912	CcSEcCtD
Buprenorphine—Pain—Methotrexate—germ cell cancer	0.000114	0.000904	CcSEcCtD
Buprenorphine—Feeling abnormal—Methotrexate—germ cell cancer	0.00011	0.000871	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000109	0.000865	CcSEcCtD
Buprenorphine—ABCB1—cerebellum—germ cell cancer	0.000109	0.00198	CbGeAlD
Buprenorphine—Urticaria—Methotrexate—germ cell cancer	0.000106	0.00084	CcSEcCtD
Buprenorphine—Abdominal pain—Methotrexate—germ cell cancer	0.000106	0.000836	CcSEcCtD
Buprenorphine—Body temperature increased—Methotrexate—germ cell cancer	0.000106	0.000836	CcSEcCtD
Buprenorphine—Hypersensitivity—Methotrexate—germ cell cancer	9.83e-05	0.000779	CcSEcCtD
Buprenorphine—Asthenia—Methotrexate—germ cell cancer	9.58e-05	0.000759	CcSEcCtD
Buprenorphine—Pruritus—Methotrexate—germ cell cancer	9.44e-05	0.000748	CcSEcCtD
Buprenorphine—Diarrhoea—Methotrexate—germ cell cancer	9.13e-05	0.000723	CcSEcCtD
Buprenorphine—ABCB1—brain—germ cell cancer	8.85e-05	0.00161	CbGeAlD
Buprenorphine—Dizziness—Methotrexate—germ cell cancer	8.83e-05	0.000699	CcSEcCtD
Buprenorphine—ABCB1—lymph node—germ cell cancer	8.55e-05	0.00156	CbGeAlD
Buprenorphine—Vomiting—Methotrexate—germ cell cancer	8.49e-05	0.000672	CcSEcCtD
Buprenorphine—Rash—Methotrexate—germ cell cancer	8.42e-05	0.000667	CcSEcCtD
Buprenorphine—Dermatitis—Methotrexate—germ cell cancer	8.41e-05	0.000666	CcSEcCtD
Buprenorphine—Headache—Methotrexate—germ cell cancer	8.36e-05	0.000662	CcSEcCtD
Buprenorphine—Nausea—Methotrexate—germ cell cancer	7.93e-05	0.000628	CcSEcCtD
Buprenorphine—ABCG2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	1.62e-05	0.14	CbGpPWpGaD
Buprenorphine—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	9.33e-06	0.0806	CbGpPWpGaD
Buprenorphine—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	8.78e-06	0.0758	CbGpPWpGaD
Buprenorphine—CYP2C18—Metapathway biotransformation—NAT9—germ cell cancer	5.27e-06	0.0455	CbGpPWpGaD
Buprenorphine—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	5.05e-06	0.0436	CbGpPWpGaD
Buprenorphine—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	5.02e-06	0.0433	CbGpPWpGaD
Buprenorphine—UGT1A9—Metapathway biotransformation—NAT9—germ cell cancer	4.16e-06	0.0359	CbGpPWpGaD
Buprenorphine—CYP3A7—Metapathway biotransformation—NAT9—germ cell cancer	3.5e-06	0.0302	CbGpPWpGaD
Buprenorphine—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	2.53e-06	0.0218	CbGpPWpGaD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—OXT—germ cell cancer	2.2e-06	0.019	CbGpPWpGaD
Buprenorphine—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	2.19e-06	0.0189	CbGpPWpGaD
Buprenorphine—OPRK1—Mecp2 and Associated Rett Syndrome—FGF4—germ cell cancer	2.12e-06	0.0183	CbGpPWpGaD
Buprenorphine—CYP2C19—Metapathway biotransformation—NAT9—germ cell cancer	1.96e-06	0.0169	CbGpPWpGaD
Buprenorphine—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	1.8e-06	0.0155	CbGpPWpGaD
Buprenorphine—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	1.78e-06	0.0154	CbGpPWpGaD
Buprenorphine—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	1.52e-06	0.0132	CbGpPWpGaD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—AVP—germ cell cancer	1.51e-06	0.013	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	1.48e-06	0.0128	CbGpPWpGaD
Buprenorphine—OPRL1—Circadian rythm related genes—AVP—germ cell cancer	1.44e-06	0.0125	CbGpPWpGaD
Buprenorphine—UGT1A9—NRF2 pathway—SLC2A3—germ cell cancer	1.31e-06	0.0113	CbGpPWpGaD
Buprenorphine—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	1.18e-06	0.0102	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—OXT—germ cell cancer	1.13e-06	0.00971	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	1.01e-06	0.00874	CbGpPWpGaD
Buprenorphine—CYP2A6—NRF2 pathway—SLC2A3—germ cell cancer	1.01e-06	0.0087	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—OXT—germ cell cancer	9.4e-07	0.00812	CbGpPWpGaD
Buprenorphine—UGT1A9—PPAR Alpha Pathway—MYC—germ cell cancer	9.21e-07	0.00795	CbGpPWpGaD
Buprenorphine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	8.88e-07	0.00766	CbGpPWpGaD
Buprenorphine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	8.55e-07	0.00738	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—OXT—germ cell cancer	8.24e-07	0.00712	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—AVP—germ cell cancer	7.71e-07	0.00666	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—OXT—germ cell cancer	6.97e-07	0.00602	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—AVP—germ cell cancer	6.44e-07	0.00556	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—OXT—germ cell cancer	6.36e-07	0.00549	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	6.31e-07	0.00544	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—OXT—germ cell cancer	5.77e-07	0.00498	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—AVP—germ cell cancer	5.65e-07	0.00488	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.53e-07	0.00477	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	5.43e-07	0.00469	CbGpPWpGaD
Buprenorphine—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	5.3e-07	0.00458	CbGpPWpGaD
Buprenorphine—CYP2A6—Fluoropyrimidine Activity—TP53—germ cell cancer	4.82e-07	0.00416	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—OXT—germ cell cancer	4.8e-07	0.00415	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—AVP—germ cell cancer	4.78e-07	0.00412	CbGpPWpGaD
Buprenorphine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	4.71e-07	0.00406	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	4.67e-07	0.00403	CbGpPWpGaD
Buprenorphine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	4.62e-07	0.00399	CbGpPWpGaD
Buprenorphine—OPRL1—Circadian rythm related genes—TP53—germ cell cancer	4.55e-07	0.00393	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—AVP—germ cell cancer	4.36e-07	0.00376	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.32e-07	0.00373	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—OXT—germ cell cancer	4.21e-07	0.00364	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—AVP—germ cell cancer	3.96e-07	0.00342	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	3.79e-07	0.00327	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—OXT—germ cell cancer	3.56e-07	0.00307	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.55e-07	0.00307	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.54e-07	0.00305	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.5e-07	0.00302	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—OXT—germ cell cancer	3.41e-07	0.00294	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—AVP—germ cell cancer	3.29e-07	0.00284	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	3.2e-07	0.00277	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.94e-07	0.00253	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—FGF4—germ cell cancer	2.91e-07	0.00251	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—AVP—germ cell cancer	2.89e-07	0.00249	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—OXT—germ cell cancer	2.71e-07	0.00234	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—HRAS—germ cell cancer	2.62e-07	0.00226	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—H2AFZ—germ cell cancer	2.6e-07	0.00224	CbGpPWpGaD
Buprenorphine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	2.54e-07	0.0022	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—SLC2A3—germ cell cancer	2.48e-07	0.00214	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—OXT—germ cell cancer	2.46e-07	0.00213	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—SLC22A3—germ cell cancer	2.44e-07	0.00211	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—AVP—germ cell cancer	2.44e-07	0.00211	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—KITLG—germ cell cancer	2.39e-07	0.00206	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—OXT—germ cell cancer	2.38e-07	0.00205	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—AVP—germ cell cancer	2.34e-07	0.00202	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—OXT—germ cell cancer	2.16e-07	0.00187	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	2.14e-07	0.00184	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—OXT—germ cell cancer	2.01e-07	0.00174	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CRABP1—germ cell cancer	1.99e-07	0.00172	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—SLC2A3—germ cell cancer	1.96e-07	0.00169	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—SLC22A3—germ cell cancer	1.93e-07	0.00167	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.92e-07	0.00166	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.89e-07	0.00163	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.86e-07	0.00161	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—AVP—germ cell cancer	1.86e-07	0.00161	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—OXT—germ cell cancer	1.83e-07	0.00158	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—FGFR3—germ cell cancer	1.78e-07	0.00153	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—AVP—germ cell cancer	1.69e-07	0.00146	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	1.68e-07	0.00145	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—SLC2A3—germ cell cancer	1.66e-07	0.00144	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.66e-07	0.00143	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—SLC2A3—germ cell cancer	1.65e-07	0.00142	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—SLC22A3—germ cell cancer	1.64e-07	0.00141	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.64e-07	0.00141	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—KIT—germ cell cancer	1.63e-07	0.00141	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—AVP—germ cell cancer	1.63e-07	0.00141	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—SLC22A3—germ cell cancer	1.62e-07	0.0014	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CRABP1—germ cell cancer	1.57e-07	0.00136	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.52e-07	0.00131	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—SLC2A3—germ cell cancer	1.51e-07	0.00131	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—SLC22A3—germ cell cancer	1.49e-07	0.00129	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—AVP—germ cell cancer	1.48e-07	0.00128	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—OXT—germ cell cancer	1.46e-07	0.00126	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—AVP—germ cell cancer	1.38e-07	0.00119	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CRABP1—germ cell cancer	1.34e-07	0.00115	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CRABP1—germ cell cancer	1.32e-07	0.00114	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.29e-07	0.00112	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—OXT—germ cell cancer	1.28e-07	0.0011	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—AVP—germ cell cancer	1.25e-07	0.00108	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—FGF4—germ cell cancer	1.24e-07	0.00107	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CRABP1—germ cell cancer	1.21e-07	0.00105	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—HRAS—germ cell cancer	1.19e-07	0.00103	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—SLC2A3—germ cell cancer	1.19e-07	0.00103	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—SLC22A3—germ cell cancer	1.17e-07	0.00101	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—H2AFZ—germ cell cancer	1.11e-07	0.000958	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—FGF4—germ cell cancer	1.09e-07	0.000941	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—OXT—germ cell cancer	1.08e-07	0.000931	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—SLC2A3—germ cell cancer	1.03e-07	0.000891	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—KITLG—germ cell cancer	1.02e-07	0.000881	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—SLC22A3—germ cell cancer	1.02e-07	0.000878	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—AVP—germ cell cancer	9.98e-08	0.000861	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—H2AFZ—germ cell cancer	9.73e-08	0.00084	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CRABP1—germ cell cancer	9.57e-08	0.000826	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—SLC2A3—germ cell cancer	9.22e-08	0.000796	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FGF4—germ cell cancer	9.21e-08	0.000795	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—SLC22A3—germ cell cancer	9.08e-08	0.000784	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SLC2A3—germ cell cancer	9e-08	0.000777	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MYC—germ cell cancer	8.98e-08	0.000775	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—KITLG—germ cell cancer	8.95e-08	0.000773	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SLC22A3—germ cell cancer	8.86e-08	0.000765	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	8.86e-08	0.000765	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—AVP—germ cell cancer	8.75e-08	0.000755	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	8.57e-08	0.00074	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SLC2A3—germ cell cancer	8.48e-08	0.000732	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SLC2A3—germ cell cancer	8.4e-08	0.000725	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SLC22A3—germ cell cancer	8.35e-08	0.000721	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CRABP1—germ cell cancer	8.29e-08	0.000716	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SLC22A3—germ cell cancer	8.28e-08	0.000715	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—H2AFZ—germ cell cancer	8.22e-08	0.00071	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—FGFR3—germ cell cancer	7.59e-08	0.000655	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—KITLG—germ cell cancer	7.57e-08	0.000653	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CRABP1—germ cell cancer	7.4e-08	0.000639	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—AVP—germ cell cancer	7.4e-08	0.000638	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TP53—germ cell cancer	7.37e-08	0.000637	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CRABP1—germ cell cancer	7.22e-08	0.000624	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SLC2A3—germ cell cancer	7.18e-08	0.00062	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SLC22A3—germ cell cancer	7.07e-08	0.000611	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HRAS—germ cell cancer	7.05e-08	0.000609	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	7.04e-08	0.000608	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—KIT—germ cell cancer	6.97e-08	0.000601	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CRABP1—germ cell cancer	6.81e-08	0.000588	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CRABP1—germ cell cancer	6.75e-08	0.000583	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—FGFR3—germ cell cancer	6.65e-08	0.000574	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—KIT—germ cell cancer	6.11e-08	0.000527	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CRABP1—germ cell cancer	5.77e-08	0.000498	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FGFR3—germ cell cancer	5.62e-08	0.000485	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SLC2A3—germ cell cancer	5.54e-08	0.000478	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SLC22A3—germ cell cancer	5.46e-08	0.000471	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—KIT—germ cell cancer	5.16e-08	0.000446	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HRAS—germ cell cancer	5.1e-08	0.00044	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HRAS—germ cell cancer	4.47e-08	0.000386	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CRABP1—germ cell cancer	4.45e-08	0.000384	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MYC—germ cell cancer	3.83e-08	0.000331	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HRAS—germ cell cancer	3.78e-08	0.000326	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MYC—germ cell cancer	3.36e-08	0.00029	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TP53—germ cell cancer	3.15e-08	0.000272	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HRAS—germ cell cancer	3.01e-08	0.00026	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MYC—germ cell cancer	2.84e-08	0.000245	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TP53—germ cell cancer	2.76e-08	0.000238	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HRAS—germ cell cancer	2.64e-08	0.000228	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TP53—germ cell cancer	2.33e-08	0.000201	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HRAS—germ cell cancer	2.23e-08	0.000193	CbGpPWpGaD
